What did Boston Scientific Corporation pay for Elutia BioEnvelope Business?

Boston Scientific Corporation acquired Elutia BioEnvelope Business for $88.0M in 2025, equivalent to 6.30x revenue. Target revenue was approximately $14.0M.

What does Elutia BioEnvelope Business do?

Elutia BioEnvelope Business is a medical devices business.

What multiple did Boston Scientific Corporation pay for Elutia BioEnvelope Business?

6.30x revenue, based on disclosed deal value of $88.0M and disclosed financials.

M&A TRANSACTION · 2025

Elutia BioEnvelope Business acquired by Boston Scientific Corporation

$88.0M· 6.30x revenue

Target

Elutia BioEnvelope Business

Acquirer

Boston Scientific Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$14.0M

EBITDA

—

Deal Value

$88.0M

EV/EBITDA

—

Context

This $88.0M acquisition of Elutia BioEnvelope Business by Boston Scientific Corporation sits in the medical devices sub-vertical. Boston Scientific Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases and earnings releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Elutia BioEnvelope Business acquisition.

Citation: ExitValue.ai. (2025). Elutia BioEnvelope Business acquired by Boston Scientific Corporation. https://exitvalue.ai/deals/elutia-bioenvelope-business-acquired-by-boston-scientific-corporation-hc-2025-0006